Boosting 5-ALA-based photodynamic therapy by a liposomal nanomedicine through intracellular iron ion regulation.
Acta Pharm Sin B
; 11(5): 1329-1340, 2021 May.
Article
in En
| MEDLINE
| ID: mdl-34094837
5-ALA, 5-aminolevulinic acid; 5-Aminolevulinic acid; ALKBH2; Biotransformation interference; CH, cholesterol; CLs, custom liposomes; Ce6, chlorine e6; DFO, deferoxamine; DNA repair inhibition; DOPC, 1,2-dioleoyl-sn-glycero-3-phosphocholine; DOPE, dioleoyl phosphatidy lethanolamine; DPPC, dipalmitoyl-sn-glycero-3-phosphocholine; Drug delivery; FBS, fetal bovine serum; H&E, hematoxylin and eosin; Iron ion regulation; LMPA, low melting point agarose; MFLs, membrane fusion liposomes; Membrane fusion liposomes; NMPA, normal melting point agarose; PDT, photodynamic therapy; PS, photosensitizers; Photodynamic therapy; PpIX, protoporphyrin IX; ROS, reactive oxygen species; SM, sphingomyelin; TUNEL, terminal deoxynucleotidyl trans-ferase dUTP nick end labeling; calcein-AM/PI, calcein-AM/ propidiumiodide
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Language:
En
Journal:
Acta Pharm Sin B
Year:
2021
Document type:
Article
Affiliation country:
Country of publication: